CD24 and cancer: As technology improves, making it possible to produce dyes with favorable optical and physical properties and spurring the development from mAb to antibody fragments and nanobodies, CD24-FIGS has the potential to move to clinical use in EOC and various different cancer debulking and whole organ excision surgeries.